Biohybrid strategies for vascular grafts

Tissue Engineering: From Lab to Clinic

Volumn 9783642028243, Issue , 2011, Pages 279-316

  Van Lith, Robert ^a   Ameer, Guillermo A ^a,b  

^a Northwestern University   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOLOGY;

CORONARY HEART DISEASE; VASCULAR GRAFTS;

CARDIOVASCULAR SURGERY;

EID: 84857794587     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-3-642-02824-3_15     Document Type: Chapter

References (245)

1. Akowuah EF, Sheridan PJ, Cooper GJ and Newman C, Preventing saphenous vein graft failure: does gene therapy have a role? Ann Thorac Surg. 2003;76(3):959-66.
2. Aldenhoff YB, van Der Veen FH, ter Woorst J, Habets J, Poole-Warren LA and Koole LH, Performance of a polyurethane vascular prosthesis carrying a dipyridamole (Persantin) coating on its lumenal surface. J Biomed Mater Res. 2001;54(2):224-33.
3. Alexander JH, Hafley G, Harrington RA, Peterson ED, Ferguson TB, Lorenz TJ, et al., Efficacy and safety of edifoligide, an E2F transcription factor decoy, for prevention of vein graft failure following coronary artery bypass graft surgery: PREVENT IV: A randomized controlled trial. JAMA. 2005;294(19):2446-54.
4. al-Khaffaf H and Charlesworth D, Albumin-coated vascular prostheses: A five-year follow-up. J Vasc Surg. 1996; 23(4):686-90.
5. Allen J, Khan S, Lapidos K and Ameer G, Toward engineering a human neoendothelium with circulating progenitor cells. Stem Cells, 2010;28(2):318-28.
6. Allen J, Khan S, Serrano MC and Ameer G, Characterization of Porcine Circulating Progenitor Cells: Toward a Functional Endothelium. Tissue Eng. 2008;14:183-94.
7. Alobaid N, Salacinski HJ, Sales KM, Ramesh B, Kannan RY, Hamilton G, et al., Nanocomposite containing bioactive peptides promote endothelialisation by circulating progenitor cells: An In vitro. Eur J Vasc Endovasc Surg. 2006;32(1):76-83.
8. Anamelechi CC, Clermont EE, Brown MA, Truskey GA and Reichert WM, Streptavidin binding and endothelial cell adhesion to biotinylated fibronectin. Langmuir. 2007; 23(25):12583-8.
9. Arts CHP, Hedeman Joosten PPA, Blankensteijn JD, Staal FJT, Ng PYY, Heijnen-Snyder GJ, et al., Contaminants from the transplant contribute to intimal hyperplasia associated with microvascular endothelial cell. Eur J Vasc Endovasc Surg. 2002;23(1):29-38.
10. Asahara T, Murohara T, Sullivan A, Silver M, van der Zee R, Li T, et al., Isolation of putative progenitor endothelial cells for angiogenesis. Science.1997;275(5302):964-7.
11. Bader A, Steinhoff G, Strobl K, Schilling T, Brandes G, Mertsching H, et al., Engineering of human vascular aortic tissue based on a xenogeneic starter matrix. Transplantation, 2000;70(1):7-14.
12. Baguneid MS, Seifalian AM, Salacinski HJ, Murray D, Hamilton G and Walker MG, Tissue engineering of blood vessels. Br J Surg.2006;93(3):282-90.
13. Banno H, Takei Y, Muramatsu T, Komori K and Kadomatsu K, Controlled release of small interfering RNA targeting midkine attenuates intimal hyperplasia in vein grafts. J Vasc Surg. 2006;44(3):633-41.
14. Barnes MJ and MacIntyre DE, Platelet-reactivity of isolated constituents of the blood vessel wall. Haemostasis, 1979;8(3-5):158-70.
15. Bernex F, Mazzucotelli JP, Roudiere JL, Benhaiem-Sigaux N, Leandri J and Loisance D, In vitro endothelialization of carbon-coated Dacron vascular grafts. Int J Artif Organs. 1992;15(3):172-80.
16. Bhardwaj S, Roy H, Heikura T and Ylä-Herttuala S, VEGF-A, VEGF-D and VEGF-D(DeltaNDeltaC) induced intimal hyperplasia in carotid arteries. Eur J Clin Invest.2005;35(11):669-76.
17. Bhat VD, Truskey GA and Reichert WM, Using avidin-mediated binding to enhance initial endothelial cell attachment and spreading. J Biomed Mater Res. 1998;40(1):57-65.
18. Bos GW, Scharenborg NM, Poot AA, Engbers GH, Terlingen JG, Beugeling T, et al., Adherence and proliferation of endothelial cells on surface-immobilized albumin-heparin conjugate. Tissue Eng.1998;4(3):267-79.
19. Bosiers M, Deloose K, Verbist J, Schroe H, Lauwers G, Lansink W, et al., Heparin-bonded expanded polytetrafluo roethylene vascular graft for femoropopliteal and femorocrural bypass grafting. J Vasc Surg.2006;43(2):313-8.
20. Brewster LP, Brey EM, Tassiopoulos AK, Xue L, Maddox E, Armistead D, et al., Heparin-independent mitogenicity in an endothelial and smooth muscle cell chimeric growth factor (S130K-HBGAM). Am J Surg.2004;188(5):575-9.
21. Cagiannos C, Abul-Khoudoud OR, DeRijk W, Shell DH, Jennings LK, Tolley EA, et al., Rapamycin-coated expanded polytetrafluoroethylene bypass grafts exhibit decreased anastomotic neointimal hyperplasia in a porcine model. J Vasc Surg. 2005;42(5):980-8.
22. Carr HMH, Vohra R, Sharma H, Smyth JV, Rooney OB, Dodd PDF, et al., Endothelial Cell Seeding Kinetics Under Chronic Flow in Prosthetic Grafts. Annals of Vascular Surgery, 1996;10(5):469-75.
23. Chandy T, Das GS, Wilson RF and Rao GHR, Use of plasma glow for surface-engineering biomolecules to enhance bloodcompatibility of Dacron and PTFE vascular. Biomaterials, 2000;21(7):699-712.
24. Chen C, Ofenloch JC, Yianni YP, Hanson SR and Lumsden AB, Phosphorylcholine Coating of ePTFE Reduces Platelet Deposition and Neointimal Hyperplasia in Arteriovenous Grafts. J Surg Res. 1998;77(2):119-25.
25. Chen H, Chen Y, Sheardown H and Brook MA, Immobilization of heparin on a silicone surface through a heterobifunctional PEG spacer. Biomaterials, 2005;26(35):7418-24.
26. Chung HJ and Park TG, Surface engineered and drug releasing pre-fabricated scaffolds for tissue engineering. Adv Drug Deliv Rev.2007;59(4-5):249-62.
27. Clarke DR, Lust RM, Sun YS, Black KS and Ollerenshaw JD, Transformation of nonvascular acellular tissue matrices into durable vascular conduits. Ann Thorac Surg. 2001; 71(5):S433-6.
28. Co M, Tay E, Lee CH, Poh KK, Low A, Lim J, et al., Use of endothelial progenitor cell capture stent (Genous Bio- Engineered R Stent) during primary percutaneous coronary. Am Heart J. 2008;155(1):128-32.
29. Crombez M, Chevallier P, Gaudreault RC, Petitclerc E, Mantovani D and Laroche G, Improving arterial prosthesis neo-endothelialization: Application of a proactive VEGF construct onto PTFE surfaces. Biomaterials, 2005;26(35):7402-9.
30. Daly CD, Campbell GR, Walker PJ and Campbell JH, In vivo engineering of blood vessels. Front Biosci. 2004;9:1915-24.
31. De Laporte L, Cruz Rea J and Shea LD, Design of modular nonviral gene therapy vectors. Biomaterials, 2006;27(7):947-54.
32. De Long SA, Moon JJ and West JL, Covalently immobilized gradients of bFGF on hydrogel scaffolds for directed cell migration. Biomaterials, 2005;26(16):3227-34.
33. Devine C, McCollum C and North West Femoro-Popliteal Trial P, Heparin-bonded Dacron or polytetrafluorethylene for femoropopliteal bypass: five-year results of a prospective randomized multicenter clinical trial. J Vasc Surg. 2004;40(5):924-31.
34. Dorrucci V, Griselli F, Petralia G, Spinamano L and Adornetto R, Heparin-bonded expanded polytetrafluoroethylene grafts for infragenicular bypass in patients with critical limb ischemia: 2-year results. J Cardiovasc Surg. 2008;49(2):145-9.
35. Eberhart RC, Munro MS, Williams GB, Kulkarni PV, Shannon WA, Brink BE, et al., Albumin adsorption and retention on C18-alkyl-derivatized polyurethane vascular grafts. Artif Organs.1987;11(5):375-82.
36. Edelman, ER, Nathan A, Katada M, Gates J and Karnovsky MJ, Perivascular graft heparin delivery using biodegradable polymer wraps. Biomaterials, 2000;21(22):2279-86.
37. Edelman ER, Nathan A, Katada M, Gates J and Karnovsky MJ, Perivascular graft heparin delivery using biodegradable polymer wraps. Biomaterials, 2000;21(22):2279-86.
38. Edwards WS, Mohtashemi M and Holdefer WF, The importance of proper caliber of lumen in femoral popliteal arterial reconstruction. J Cardiovasc Surg. 1967;8(3):195-7.
39. Evangelista RA and Sefton MV, Coating of two polyetoerpolyurethanes and polyethylene with a heparin-poly-(vinyl alcohol) hydrogel. Biomaterials, 1986;7(3):206-11.
40. Fauvel-Lafève F and Kwang WJ, Microfibrils from the Arterial Subendothelium, in International Review of Cytology; 1999:1-40.
41. Feng S-S, Zeng W, Teng Lim Y, Zhao L, Yin Win K, Oakley R, et al., Vitamin E TPGS-emulsified poly(lactic-co-glycolic acid) nanoparticles for cardiovascular restenosis treatment. Nanomedicine.2007;2(3):333-44.
42. Fleser PS, Nuthakki VK, Malinzak LE, Callahan RE, Seymour ML, Reynolds MM, et al., Nitric oxide-releasing biopolymers inhibit thrombus formation in a sheep model of arteriovenous bridge grafts. J Vasc Surg.2004;40(4):803-11.
43. Frost MC and Meyerhoff ME, Synthesis, characterization, and controlled nitric oxide release from S-nitrosothiolderivatized fumed silica polymer filler particles. J Biomed Mater Res A. 2005;72(4):409-19.
44. Frost MC, Reynolds MM and Meyerhoff ME, Polymers incorporating nitric oxide releasing/generating substances for improved biocompatibility of blood-contacting. Biomaterials, 2005;26(14):1685-93.
45. Galli M, Bartorelli A, Bedogni F, De Cesare N, Klugmann S, Maiello L, et al., Italian BiodivYsio open registry (BiodivYsio PC-coated stent): Study of clinical outcomes of the implant of a PC-coated coronary stent. J Invasive Cardiol. 2000; 12(9):452-8.
46. George SJ, Angelini GD, Capogrossi MC and Baker AH, Wild-type p53 gene transfer inhibits neointima formation in human saphenous vein by modulation of smooth muscle cell migration. Gene Ther. 2001;8(9):668-76.
47. Gong Z and Niklason LE, Blood Vessels Engineered from Human Cells. Trends Cardiovasc Med. 2006;16(5):153-6.
48. Gorbet MB and Sefton MVMV, Biomaterial-associated thrombosis: roles of coagulation factors, complement, platelets and leukocytes. Biomaterials, 2004;25(26):5681-703.
49. Gosselin C, Vorp DA, Warty V, Severyn DA, Dick EK, Borovetz HS, et al., ePTFE coating with fibrin glue, FGF-1, and heparin: effect on retention of seeded endothelial cells. The J Surg Res. 1996;60(2):327-32.
50. Gray JL, Kang SS, Zenni GC, Kim DU, Kim PI, Burgess WH, et al., FGF-1 affixation stimulates ePTFE endothelialization without intimal hyperplasia. The J Surg Res. 1994;57(5):596-612.
51. Greco RS, Kim HC, Donetz AP and Harvey RA, Patency of a Small Vessel Prosthesis Bonded to Tissue Plasminogen Activator and Iloprost. Ann Vasc Surg.1995;9(2):140-5.
52. Guidoin R, Chakfe N, Maurel S, How T, Batt M, Marois M, et al., Expanded polytetrafluoroethylene arterial prostheses in humans: Histopathological study of 298 surgically excised grafts. Biomaterials, 1993;14(9):678-93.
53. Hacker TA, Griffin MO, Guttormsen B, Stoker S and Wolff MR, Platelet-derived growth factor receptor antagonist STI571 (imatinib mesylate) inhibits human vascular smooth muscle proliferation and migration in vitro but not in vivo. J Invasive Cardiol.2007;19(6):269-74.
54. Han DK, Park K, Park KD, Ahn K-D and Kim YH, In vivo biocompatibility of sulfonated PEO-grafted polyurethanes for polymer heart valve and vascular graft. Artif Organs.2006;30(12):955-9.
55. Haruguchi H and Teraoka S, Intimal hyperplasia and hemodynamic factors in arterial bypass and arteriovenous grafts: A review J Artif Organs. 2003;6(4):227-35.
56. He H, Shirota T, Yasui H and Matsuda T, Canine endothelial progenitor cell-lined hybrid vascular graft with nonthrombogenic potential. J Thorac Cardiovasc Surg. 2003;126(2):455-64.
57. Hedeman Joosten PP, Verhagen HJ, Heijnen-Snyder GJ, Sixma JJ, de Groot PG, Eikelboom BC, et al., Thrombomodulin activity of fat-derived microvascular endothelial cells seeded on expanded polytetrafluorethylene. J Vasc Res. 1999;36(2):91-9.
58. Heise M, Schmidmaier G, Husmann I, Heidenhain C, Schmidt J, Neuhaus P, et al., PEG-hirudin/iloprost coating of small diameter ePTFE grafts effectively prevents pseudointima and intimal hyperplasia development. Eur J Vasc Endovasc Surg.2006;32(4):418-24.
59. Herold DA, Keil K and Bruns DE, Oxidation of polyethylene glycols by alcohol dehydrogenase. Biochem Pharmacol. 1989;38(1):73-6.
60. Hersel U, Dahmen C and Kessler H, RGD modified polymers: biomaterials for stimulated cell adhesion and beyond. Biomaterials, 2003;24(24):4385-415.
61. Heyligers JMM, Verhagen HJM, Rotmans JI, Weeterings C, de Groot PG, Moll FL, et al., Heparin immobilization reduces thrombogenicity of small-caliber expanded polytetrafluoroethylene grafts. J Vasc Surg.2006;43(3):587-91.
62. Higgins SP, Solan AK and Niklason LE, Effects of polyglycolic acid on porcine smooth muscle cell growth and differentiation. J Biomed Mater Res A. 2003;67(1):295-302.
63. Hoenig MR, Campbell GR, Rolfe BE and Campbell JH, Tissue-engineered blood vessels: Alternative to autologous grafts? Arterioscler Thromb Vasc Biol. 2005;25(6):1128-34.
64. Hoerstrup SP, Cummings Mrcs I, Lachat M, Schoen FJ, Jenni R, Leschka S, et al., Functional Growth in Tissue- Engineered Living, Vascular Grafts: Follow-Up at 100 Weeks in a Large Animal Model. 2006. p. 159-66.
65. Hu Y, Litwin T, Nagaraja AR, Kwong B, Katz J, Watson N, et al., Cytosolic delivery of membrane-impermeable molecules in dendritic cells using pH-responsive core-shell nanoparticles. Nano Lett.2007;7(10):3056-64.
66. Huang B, Dreyer T, Heidt M, Yu JCM, Philipp M, Hehrlein FW, et al., Insulin and local growth factor PDGF induce intimal hyperplasia in bypass graft culture models of saphenous vein and internal mammary artery. Eur J Cardiothorac Surg. 2002;21(6):1002-8.
67. Hubbell JA, Massia SP, Desai NP and Drumheller PD, Endothelial Cell-Selective Materials for Tissue Engineering in the Vascular Graft Via a New Receptor. Nat Biotech, 1991;9(6):568-72.
68. Hwang S and Meyerhoff ME, Polyurethane with tethered copper(II)-cyclen complex: Preparation, characterization and catalytic generation of nitric oxide from S-nitrosothiols. Biomaterials, 2008;29(16):2443-52.
69. Ishihara K, Nomura H, Mihara T, Kurita K, Iwasaki Y and Nakabayashi N, Why do phospholipid polymers reduce protein adsorption? J Biomed Mater Res. 1998;39(2):323-30.
70. Ishii Y, Sakamoto S-I, Kronengold RT, Virmani R, Rivera EA, Goldman SM, et al., A novel bioengineered small-caliber vascular graft incorporating heparin and sirolimus: excellent 6-month patency. J Thorac Cardiovasc Surg.2008;135(6):1237-45.
71. Ishikawa Y, Sasakawa S, Takase M and Osada Y, Effect of albumin immobilization by plasma polymerization on platelet reactivity. Thromb Res.1984;35(2):193-202.
72. Iwasaki K, Kojima K, Kodama S, Paz AC, Chambers M, Umezu M, et al., Bioengineered three-layered robust and elastic artery using hemodynamically-equivalent pulsatile bioreactor. Circulation, 2008;118(14 Suppl):52-7.
73. Iwasaki Y and Ishihara K, Phosphorylcholine-containing polymers for biomedical applications. Anal Bioanal Chem.2005;381(3):534-46.
74. Jabara R, Chronos N, Hnojewyj O, Rivelli P and Robinson K, Assessment of a novel anti-inflammatory salicylic-acidbased polymer for use in fully biodegradable coronary stents. Cardiovasc Revasc Med. 2007;8(2):131-2.
75. Jackson JK, Smith J, Letchford K, Babiuk KA, Machan L, Signore P, et al., Characterization of perivascular poly(lacticco- glycolic acid) films containing paclitaxel. Int J Pharm. 2004;283(1):97-109.
76. Jones MI, McColl IR, Grant DM, Parker KG and Parker TL, Protein adsorption and platelet attachment and activation, on TiN, TiC, and DLC coatings on titanium for cardiovascular applications. J Biomed Mater Res. 2000;52:413-21.
77. Jordan SW, Faucher KM, Caves JM, Apkarian RP, Rele SS, Sun X-L, et al., Fabrication of a phospholipid membranemimetic film on the luminal surface of an ePTFE vascular graft. Biomaterials, 2006;27(18):3473-81.
78. Jordan SW, Haller CA, Sallach RE, Apkarian RP, Hanson SR and Chaikof EL, The effect of a recombinant elastinmimetic coating of an ePTFE prosthesis on acute thrombogenicity in a baboon arteriovenous shunt. Biomaterials, 2007;28(6):1191-7.
79. Kakisis JD, Liapis CD, Breuer C and Sumpio BE, Artificial blood vessel: The Holy Grail of peripheral vascular surgery. J Vasc Surg, 2005;41:349-54.
80. Kaladhar CPS, Cell mimetic lateral stabilization of outer cell mimetic bilayer on polymer surfaces by peptide bonding and their blood compatibility. J Biomed Mat Res, 2006. p. 23-35.
81. Kannan RY, Salacinski HJ, Butler PE, Hamilton G and Seifalian AM, Current status of prosthetic bypass grafts: A review. J Biomed Mat Res Part B Appl Biomater, 2005;74(1):570-81.
82. Kapadia MR, Chow LW, Tsihlis ND, Ahanchi SS, Eng JW, Murar J, et al., Nitric oxide and nanotechnology: A novel approach to inhibit neointimal hyperplasia. J Vasc Surg, 2008;47(1):173-82.
83. Kapadia MR, Popowich DA and Kibbe MR, Modified prosthetic vascular conduits. Circulation, 2008;117(14):1873-82.
84. Kapfer X, Meichelboeck W and Groegler FM, Comparison of carbon-impregnated and standard ePTFE prostheses in extra-anatomical anterior tibial artery bypass: A prospective randomized multicenter study. Eur J Vasc Endovasc Surg. 2006;32(2):155-68.
85. Karakayali F, Haberal N, Tufan H, Hasirci N, Basaran O, Sevmis S, et al., Evaluation of neointimal hyperplasia on tranilast-coated synthetic vascular grafts: An experimental study. J Investig Surg.2007;20(3):167-73.
86. Karrer L, Duwe J, Zisch AH, Khabiri E, Cikirikcioglu M, Napoli A, et al., PPS-PEG surface coating to reduce thrombogenicity of small diameter ePTFE vascular grafts. Int J Artif Organs. 2005;28(10):993-1002.
87. Kaushal S, Amiel GE, Guleserian KJ, Shapira OM, Perry T, Sutherland FW, et al., Functional small-diameter neovessels created using endothelial progenitor cells expanded ex vivo. Nature medicine, 2001;7(9):1035-40.
88. Kibbe MR, Tzeng E, Gleixner SL, Watkins SC, Kovesdi I, Lizonova A, et al., Adenovirus-mediated gene transfer of human inducible nitric oxide synthase in porcine vein grafts inhibits intimal hyperplasia. J Vasc Surg. 2001;34(1):156-65.
89. Kim W, Jeong MH, Kim KH, Sohn IS, Hong YJ, Park HW, et al., The Clinical Results of a Platelet Glycoprotein IIb/IIIa Receptor Blocker (Abciximab: ReoPro)-Coated Stent in Acute. J Am Coll Cardiol.2006;47(5):933-8.
90. Klinkert P, Schepers A, Burger DHC, Bockel JHv and Breslau PJ, Vein versus polytetrafluoroethylene in aboveknee femoropopliteal bypass grafting: Five-year results of a randomized. J Vasc Surg.2003;37(1):149-55.
91. Köhler AS, Parks PJ, Mooradian DL, Rao GHR and Furcht LT, Platelet adhesion to novel phospholipid materials: Modified phosphatidylcholine covalently immobilized to silica, polypropylene, and PTFE materials. J Biomed Mater Res A. 1996;32(2):237-42.
92. Kohler TR, Toleikis PM, Gravett DM and Avelar RL, Inhibition of neointimal hyperplasia in a sheep model of dialysis access failure with the bioabsorbable Vascular Wrap paclitaxel-eluting mesh. J Vasc Surg. 2007;45(5):1029-37.
93. Kong D, Melo LG, Mangi AA, Zhang L, Lopez-Ilasaca M, Perrella MA, et al., Enhanced inhibition of neointimal hyperplasia by genetically engineered endothelial progenitor cells. Circulation, 2004;109(14):1769-75.
94. Konner K, Paclitaxel - A tool to prevent stenosis in vascular access for haemodialysis? Blood Purif. 2006;24(3):287-8.
95. Kottke-Marchant K, Anderson JM, Umemura Y and Marchant RE, Effect of albumin coating on the in vitro blood compatibility of Dacron(R) arterial prostheses. Biomaterials, 1989;10(3):147-55.
96. Köveker GB, Graham LM, Burkel WE, Sell R, Wakefield TW, Dietrich K, et al., Extracellular matrix preparation of expanded polytetrafluoroethylene grafts seeded with endothelial cells: Influence on early platelet deposition, cellular growth, and luminal prostacyclin release. Surgery. 1991;109(3 Pt 1):313-9.
97. Krenning G, Dankers PYW, Jovanovic D, van Luyn MJA and Harmsen MC, Efficient differentiation of CD14+ monocytic cells into endothelial cells on degradable biomaterials. Biomaterials, 2007;28(8):1470-9.
98. Kudo FA, Nishibe T, Miyazaki K, Flores J and Yasuda K, Albumin-coated knitted Dacron aortic prosthses. Study of postoperative inflammatory reactions. Int Angiol. 2002; 21(3):214-7.
99. Kuiper KK, Robinson KA, Chronos NA, Cui J, Palmer SJ and Nordrehaug JE, Phosphorylcholine-coated metallic stents in rabbit iliac and porcine coronary arteries. Scandinavian cardiovascular journal: SCJ, 1998;32(5):261-8.
100. Kuji T, Masaki T, Goteti K, Li L, Zhuplatov S, Terry CM, et al., Efficacy of local dipyridamole therapy in a porcine model of arteriovenous graft stenosis. Kidney Int. 2006;69(12):2179-85.
101. L'Heureux N, Dusserre N, Konig G, Victor B, Keire P, Wight TN, et al., Human tissue-engineered blood vessels for adult arterial revascularization. Nature Medicine, 2006;12(3):361-5.
102. L'Heureux N, Dusserre N, Marini A, Garrido S, de la Fuente L and McAllister T, Technology Insight: The evolution of tissue-engineered vascular grafts from research to clinical practice. Nat Clin Pract Cardiovasc Med. 2007;4(7):389-95.
103. L'Heureux N, McAllister TN and de la Fuente LM, Tissue- Engineered Blood Vessel for Adult Arterial Revascularization. N Eng J Med. 2007. p. 1451-3.
104. L'Heureux N, Paquet S, Labbe R, Germain L, Auger FA. A completely biological tissue-engineered human blood vessel. FASEB J. 1998;12(1):47-56.
105. Lahtinen M, Blomberg P, Baliulis G, Carlsson F, Khamis H and Zemgulis V, In vivo h-VEGF165 gene transfer improves early endothelialisation and patency in synthetic vascular grafts. Eur J Cardiothorac Surg. 2007. p. 383-90.
106. Lamm P, Juchem G, Milz S, Schuffenhauer M and Reichart B, Autologous endothelialized vein allograft: A solution in the search for small-caliber grafts in coronary artery bypass graft operations. Circulation, 2001;104(12):108-14.
107. Laredo J, Xue L, Husak VA, Ellinger J, Singh G, Zamora PO, et al., Silyl-heparin bonding improves the patency and in vivo thromboresistance of carbon-coated polytetrafluoroethylene. J Vasc Surg.2004;39(5):1059-65.
108. Larsen CC, Kligman F, Tang C, Kottke-Marchant K and Marchant RE, A biomimetic peptide fluorosurfactant polymer for endothelialization of ePTFE with limited platelet adhesion. Biomaterials, 2007;28(24):3537-48.
109. Lee BH, Nam HY, Kwon T, Kim SJ, Kwon GY, Jeon HJ, et al., Paclitaxel-coated expanded polytetrafluoroethylene haemodialysis grafts inhibit neointimal hyperplasia in porcine model of graft stenosis. Nephrol Dial Transplant. 2006;21(9):2432-8.
110. Lewis AL and Stratford PW, Phosphorylcholine-coated stents. J Long Term Eff Med Implants. 2002;12(4):231-50.
111. Li C, Hill A and Imran M, In vitro and in vivo studies of ePTFE vascular grafts treated with P15 peptide. J Biomater Sci Polym. Ed. 2005;16(7):875-91.
112. Li J-m, Singh MJ, Nelson PR, Hendricks GM, Itani M, Rohrer MJ, et al., Immobilization of human thrombomodulin to expanded polytetrafluoroethylene. The J Surg Res. 2002;105(2):200-8.
113. Li L, Terry CM, Shiu Y-TE and Cheung AK, Neointimal hyperplasia associated with synthetic hemodialysis grafts. Kidney Int. 2008;74(10):1247-61.
114. Lim HJ, Nam HY, Lee BH, Kim DJ, Ko JY and Park J-S, A novel technique for loading of paclitaxel-PLGA nanoparticles onto ePTFE vascular grafts. Biotechnology progress, 2007;23(3):693-7.
115. Lin PH, Chen C, Bush RL, Yao Q, Lumsden AB and Hanson SR, Small-caliber heparin-coated ePTFE grafts reduce platelet deposition and neointimal hyperplasia in a baboon model. J Vasc Surg.2004;39(6):1322-8.
116. Lin W-C, Tseng C-H and Yang M-C, In-vitro hemocompatibility evaluation of a thermoplastic polyurethane membrane with surface-immobilized water-soluble chitosan and heparin. Macromolecular bioscience, 2005;5(10):1013-21.
117. Liu SQ, Tieche C and Alkema PK, Neointima formation on vascular elastic laminae and collagen matrices scaffolds implanted in the rat aortae. Biomaterials, 2004; 25(10):1869-82.
118. Liu Y, Bohr VA and Lansdorp P, Telomere, telomerase and aging. Mech Ageing Dev. 2008;129(1):1-2.
119. Lo C, Li J, Nelson PR, Morris M, Vasiliu C, Rohrer MJ, et al., Superior performance of thrombomodulin coated small caliber ePTFE grafts. J Surg Res. 2003;114(2):263-4.
120. Long JL and Tranquillo RT, Elastic fiber production in cardiovascular tissue-equivalents. Matrix Biol. 2003;22(4):339-50.
121. Lu A and Sipehia R, Antithrombotic and fibrinolytic system of human endothelial cells seeded on PTFE: The effects of surface modification of PTFE by ammonia plasma treatment and ECM protein coatings. Biomaterials, 2001;22(11):1439-46.
122. Lu JR, Murphy EF, Su TJ, Lewis AL, Stratford PW and Satija SK, Reduced Protein Adsorption on the Surface of a Chemically Grafted Phospholipid Monolayer. Langmuir. 2001;17:3382-9.
123. Luong-Van E, Grøndahl L, Chua KN, Leong KW, Nurcombe V and Cool SM, Controlled release of heparin from poly(epsilon-caprolactone) electrospun fibers. Biomaterials, 2006;27(9):2042-50.
124. Lytle BW, Prolonging patency-choosing coronary bypass grafts. N Eng J Med. 2004;351(22):2262-4.
125. Maechling-Strasser C, Déjardin P, Galin JC, Schmitt A, Housse-Ferrari V, Sébille B, et al., Synthesis and adsorption of a poly(N-acetylethyleneimine)-polyethyleneoxidepoly (N-acetylethyleneimine) triblock-copolymer at a silica/solution interface. Influence of its preadsorption on platelet adhesion and fibrinogen adsorption. J Biomed Mater Res. 1989;23(12):1395-410.
126. Makiyama Y, Toba K, Kato K, Hirono S, Ozawa T, Saigawa T, et al., Imatinib mesilate inhibits neointimal hyperplasia via growth inhibition of vascular smooth muscle cells in a rat model of balloon injury. Tohoku J Exp Med. 2008;215(4):299-306.
127. Markway BD, McCarty OJT, Marzec UM, Courtman DW, Hanson SR and Hinds MT, Capture of flowing endothelial cells using surface-immobilized anti-kinase insert domain receptor antibody. Tissue Eng. 2008;14(2):97-105.
128. Marois Y, Chakfé N, Guidoin R, Duhamel RC, Roy R, Marois M, et al., An albumin-coated polyester arterial graft: In vivo assessment of biocompatibility and healing characteristics. Biomaterials, 1996;17(1):3-14.
129. Marra KG, Kidani DDA and Chaikof EL, Cytomimetic Biomaterials. 2. In-Situ Polymerization of Phospholipids on a Polymer Surface. Langmuir. 1997;13:5697-701.
130. Masaki T, Rathi R, Zentner G, Leypoldt JK, Mohammad SF, Burns GL, et al., Inhibition of neointimal hyperplasia in vascular grafts by sustained perivascular delivery of paclitaxel. Kidney Int. 2004;66(5):2061-9.
131. Matsumura G, Hibino N, Ikada Y, Kurosawa H and Shin'oka T, Successful application of tissue engineered vascular autografts: clinical experience. Biomaterials, 2003;24(13):2303-8.
132. Matyas L, Berry M, Menyhei G, Tamas L, Acsady G, Cuypers P, et al., The Safety and Efficacy of a Paclitaxel-eluting Wrap for Preventing Peripheral Bypass Graft Stenosis: A 2-Year. Eur J Vasc Endovasc Surg. 2008;35(6):715-22.
133. Melhem M, Kelly B, Zhang J, Kasting G, Li J, Davis H, et al., Development of a local perivascular paclitaxel delivery system for hemodialysis vascular access dysfunction: polymer preparation and in vitro activity. Blood Purif. 2006;24(3):289-98.
134. Merrill EW, Salzman E.W., Polyethylene oxide as a biomaterial. ASAIO J, 1983;29(6 ):80-4.
135. Miller MR, Hanspal IS, Hadoke PWF, Newby DE, Rossi AG, Webb DJ, et al., A novel S-nitrosothiol causes prolonged and selective inhibition of platelet adhesion at sites of vascular injury. Cardiovascular Research, 2003;57(3):853-60.
136. Miyake T, Aoki M, Shiraya S, Tanemoto K, Ogihara T, Kaneda Y, et al., Inhibitory effects of NFkappaB decoy oligodeoxynucleotides on neointimal hyperplasia in a rabbit vein graft model. J Mol Cell Cardiol. 2006;41(3):431-40.
137. Mizelle SW, Gupta BS and Kasyanov VA. Compliance of small-diameter vascular grafts as a determinant of patency. in Biomedical Engineering Conference, 1995., Proceedings of the 1995 Fourteenth Southern BME Conference, 1995:30-4.
138. Moon JJ, Lee S-H and West JL, Synthetic biomimetic hydrogels incorporated with ephrin-A1 for therapeutic angiogenesis. Biomacromolecules, 2007;8(1):42-9.
139. Motlagh D, Allen J, Hoshi R, Yang J, Lui K and Ameer G, Hemocompatibility evaluation of poly(diol citrate) in vitro for vascular tissue engineering. J Biomed Mater Res A. 2007;82A(4):907-16.
140. Mowery KA, Schoenfisch M, Saavedra JE, Keefer LK and Meyerhoff ME, Preparation and characterization of hydrophobic polymeric films that are thromboresistant via nitric oxide release. Biomaterials, 2000;21(1):9-21.
141. Najjar SF, Pearce C, Eng J, Aalami O, Kapadia M, Lyle B, et al., Efficacy of perivascular NO-eluting therapies for the prevention of neointimal hyperplasia. J Surg Res. 2006;130(2):205.
142. Nakao A, Nagaoka S and Mori Y, Hemocompatibility of Hydrogel with Polyethyleneoxide Chains. J Biomater Appl.1987;2(2):219-34.
143. Niklason LE, Gao J, Abbott WM, Hirschi KK, Houser S, Marini R, et al., Functional arteries grown in vitro. Science.1999;284(5413):489-93.
144. Noishiki Y, Ma XH, Yamane Y, Satoh S, Okoshi T, Takahashi K, et al., Succinylated collagen crosslinked by thermal treatment for coating vascular prostheses. Artif Organs.1998;22(8):672-80.
145. Nugent HM, Rogers C and Edelman ER, Endothelial implants inhibit intimal hyperplasia after porcine angioplasty. Circ Res. 1999;84(4):384-91.
146. Oh BK and Meyerhoff ME, Catalytic generation of nitric oxide from nitrite at the interface of polymeric films doped with lipophilic. Biomaterials, 2004;25(2):283-93.
147. Olsson P, Sanchez J, Mollnes TE and Riesenfeld J, On the blood compatibility of end-point immobilized heparin. J Biomater Sci Polym. Ed. 2000;11(11):1261-73.
148. Owens CD, Ho KJ and Conte MS, Lower extremity vein graft failure: A translational approach. Vasc Med. 2008;13:63-74.
149. Park K, Mosher DF and Cooper SL, Acute surface-induced thrombosis in the canine ex vivo model: Importance of protein composition of the initial monolayer and platelet activation. J Biomed Mater Res. 1986;20(5):589-612.
150. Pasic M, Müller-Glauser W, Odermatt B, Lachat M, Seifert B and Turina M, Seeding with omental cells prevents late neointimal hyperplasia in small-diameter Dacron grafts. Circulation, 1995;92(9):2605-16.
151. Patel A, Fine B, Sandig M and Mequanint K, Elastin biosynthesis: The missing link in tissue-engineered blood vessels. Cardiovasc Res. 2006;71(1):40-9.
152. Pearce CG, Najjar SF, Kapadia MR, Murar J, Eng J, Lyle B, et al., Beneficial effect of a short-acting NO donor for the prevention of neointimal hyperplasia. Free Radic Biol Med. 2008;44(1):73-81.
153. Peichev M, Naiyer AJ, Pereira D, Zhu Z, Lane WJ, Williams M, et al., Expression of VEGFR-2 and AC133 by circulating human CD34(+) cells identifies a population of functional endothelial precursors. Blood, 2000;95(3):952-8.
154. Pfeiffer T, Wallich M, Sandmann W, Schrader J and Godecke A, Lipoplex gene transfer of inducible nitric oxide synthase inhibits the reactive intimal hyperplasia after expanded. J Vasc Surg.2006;43(5):1021-7.
155. Phillips DR, Charo IF, Parise LV and Fitzgerald LA, The platelet membrane glycoprotein IIb-IIIa complex. Blood. 1988;71:831-43.
156. Pollara P, Alessandri G, Bonardelli S, Simonini A, Cabibbo E, Portolani N, et al., Complete in vitro prosthesis endothelialization induced by artificial extracellular matrix. J Investig Surg.1999;12(2):81-8.
157. Pulfer SK, Ott D and Smith DJ, Incorporation of nitric oxidereleasing crosslinked polyethyleneimine microspheres into vascular grafts. J Biomed Mater Res. 1997;37(2):182-9.
158. Randone B, Cavallaro G, Polistena A, Cucina A, Coluccia P, Graziano P, et al., Dual role of VEGF in pretreated experimental ePTFE arterial grafts. The J Surg Res. 2005; 127(2):70-9.
159. Raybagkar DA, Patchipulusu S, Mast AE and Hall CL, In vitro flow evaluation of recombinant tissue factor pathway inhibitor immobilized on collagen impregnated Dacron. ASAIO J. 2004;50(4):301-5.
160. Reynolds MM, Hrabie JA, Oh BK, Politis JK, Citro ML, Keefer LK, et al., Nitric oxide releasing polyurethanes with covalently linked diazeniumdiolated secondary amines. Biomacromolecules, 2006;7(3):987-94.
161. Rhim C and Niklason LE, Tissue engineered vessels: Cells to telomeres. Prog Pediatr Cardiol. 2006;21(2):185-91.
162. Ripamonti U, Van Den Heever B, Sampath TK, Tucker MM, Rueger DC and Reddi AH, Complete regeneration of bone in the baboon by recombinant human osteogenic protein- 1 (hOP-1, bone morphogenetic protein-7). Growth Factors. 1996;13(3-4):273-89.
163. Rissanen TT and Ylä-Herttuala S, Current Status of Cardiovascular Gene Therapy. Mol Ther. 2007;15(7):1233-47.
164. Rodríguez G, Gallardo A, Fernández M, Rebuelta M, Buján J, Bellón JM, et al., Hydrophilic polymer drug from a derivative of salicylic acid: Synthesis, controlled release studies and biological behavior. Macromol Biosci. 2004;4(6):579-86.
165. Romagnani P, Annunziato F, Liotta F, Lazzeri E, Mazzinghi B, Frosali F, et al., CD14+CD34low cells with stem cell phenotypic and functional features are the major source of circulating endothelial progenitors. Circ Res. 2005;97(4):314-22.
166. Rosamond W, Flegal K, Furie K, Go A, Greenlund K, Haase N, et al., Heart Disease and Stroke Statistics-2008 Update: A Report From the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation. 2008;117:e25-146.
167. Rotmans JI, Heyligers JMM, Verhagen HJM, Velema E, Nagtegaal MM, de Kleijn DPV, et al., In vivo cell seeding with anti-CD34 antibodies successfully accelerates endothelialization but stimulates intimal hyperplasia in porcine arteriovenous expanded polytetrafluoroethylene grafts. Circulation, 2005;112(1):12-8.
168. Rotmans JI, Pattynama PMT, Verhagen HJM, Hino I, Velema E, Pasterkamp G, et al., Sirolimus-eluting stents to abolish intimal hyperplasia and improve flow in porcine arteriovenous grafts: A 4-week follow-up study. Circulation, 2005;111(12):1537-42.
169. Roy-Chaudhury P, Kelly BS, Miller MA, Reaves A, Armstrong J, Nanayakkara N, et al., Venous neointimal hyperplasia in polytetrafluoroethylene dialysis grafts. Kidney Int, 2001;59(6):2325-34.
170. Rubin BG, Toursarkissian B, Petrinec D, Yang LY, Eisenberg PR and Abendschein DR, Preincubation of Dacron grafts with recombinant tissue factor pathway inhibitor decreases their thrombogenicity in vivo. J Vasc Surg. 1996;24(5):865-70.
171. San Román J, Buján J, Bellón JM, Gallardo A, Escudero MC, Jorge E, et al., Experimental study of the antithrombogenic behavior of Dacron vascular grafts coated with hydrophilic acrylic copolymers bearing salicylic acid residues. J Biomed Mater Res. 1996;32(1):19-27.
172. Sarkar S, Schmitz-Rixen T, Hamilton G and Seifalian AM, Achieving the ideal properties for vascular bypass grafts using a tissue engineered approach: A review. Med Biol Eng Comput. 2007;45(4):327-36.
173. Schachner T, Zou Y, Oberhuber A, Mairinger T, Tzankov A, Laufer G, et al., Perivascular application of C-type natriuretic peptide attenuates neointimal hyperplasia in experimental vein grafts. Eur J Cardiothorac Surg. 2004;25(4):585-90.
174. Schachner T, Oberhuber A, Zou Y, Tzankov A, Ott H, Laufer G, et al., Rapamycin treatment is associated with an increased apoptosis rate in experimental vein grafts. Eur J Cardiothorac Surg. 2005;27(2):302-6.
175. Schachner T, Pharmacologic inhibition of vein graft neointimal hyperplasia. J Thorac Cardiovasc Surg.2006;131(5):1065-72.
176. Schanzer A, Hevelone N, Owens CD, Belkin M, Bandyk DF, Clowes AW, et al., Technical factors affecting autogenous vein graft failure: Observations from a large multicenter trial. J Vasc Surg.2007;46(6):1180-90.
177. Scharn DM, Dirven M, Barendregt WB, Boll APM, Roelofs D and van der Vliet JA, Human Umbilical Vein versus Heparin-bonded Polyester for Femoro-popliteal Bypass: 5-year Results of a Prospective. Eur J Vasc Endovasc Surg. 2008;35(1):61-7.
178. Schmidt SP, Meerbaum SO, Anderson JM, Clarke RE, Zellers RA and Sharp WV, Evaluation of Expanded Polytetrafluoroethylene Arteriovenous Access Grafts onto which Microvessel-Derived Cells were Transplanted to Improve Graft Performance: Preliminary Results. Ann Vasc Surg.1998;12(5):405-11.
179. Seabra AB, de Souza GFP, da Rocha LL, Eberlin MN and de Oliveira MG, S-Nitrosoglutathione incorporated in poly(ethylene glycol) matrix: potential use for topical nitric oxide delivery. Nitric Oxide, 2004;11(3):263-72.
180. Shi Q, Wu MHD and Sauvage LR, Clinical and experimental demonstration of complete healing of porous dacron patch grafts used for closure of the arteriotomy after carotid endarterectomy. Ann Vasc Surg.1999;13(3):313-7.
181. Shin'oka T, Matsumura G, Hibino N, Naito Y, Watanabe M, Konuma T, et al., Midterm clinical result of tissue-engineered vascular autografts seeded with autologous bone marrow cells. J Thorac Cardiovasc Surg.2005;129(6):1330-8.
182. Shirota T, He H, Yasui H and Matsuda T, Human endothelial progenitor cell-seeded hybrid graft: proliferative and antithrombogenic potentials in vitro and fabrication processing. Tissue Eng.2003;9(1):127-36.
183. Shum-Tim D, Stock U, Hrkach J, Shinoka T, Lien J, Moses MA, et al., Tissue engineering of autologous aorta using a new biodegradable polymer. Ann Thorac Surg. 1999;68(6):2298-304.
184. Signore PE, Machan LS, Jackson JK, Burt H, Bromley P, Wilson JE, et al., Complete Inhibition of Intimal Hyperplasia by Perivascular Delivery of Paclitaxel in Balloon-injured Rat Carotid. J Vasc Interv Radiol.2001;12(1):79-88.
185. Simnick A, Lim DW and Chilkoti A, Biomedical and Biotechnological Applications of Elastin-Like Polypeptides. J Macromol Sci. 2007(47):121-54.
186. Simper D, Stalboerger PG, Panetta CJ, Wang S and Caplice NM, Smooth muscle progenitor cells in human blood. Circulation, 2002;106(10):1199-204.
187. Sinclair J and Salem AK, Rapid localized cell trapping on biodegradable polymers using cell surface derivatization and microfluidic networking. Biomaterials, 2006;27(9):2090-4.
188. Singh JP, Rothfuss KJ, Wiernicki TR, Lacefield WB, Kurtz WL, Brown RF, et al., Dipyridamole directly inhibits vascular smooth muscle cell proliferation in vitro and in vivo: Implications in the treatment of restenosis after angioplasty. J Am Coll Cardiol.1994;23(3):665-71.
189. Smith DJ, Chakravarthy D, Pulfer S, Simmons ML, Hrabie JA, Citro ML, et al., Nitric oxide-releasing polymers containing the [N(O)NO]- group. J Med Chem. 1996;39(5):1148-56.
190. Smith JN and Dasgupta TP, Kinetics and Mechanism of the Decomposition of S-Nitrosoglutathione by -Ascorbic Acid and Copper Ions in Aqueous Solution to Produce Nitric Oxide. Nitric Oxide, 2000;4(1):57-66.
191. Smith MJ, McClure MJ, Sell SA, Barnes CP, Walpoth BH, Simpson DG, et al., Suture-reinforced electrospun polydioxanone- elastin small-diameter tubes for use in vascular tissue engineering: A feasibility study. Acta Biomater. 2008;4(1):58-66.
192. Sperling C, König U, Hermel G, Werner C, Müller M, Simon F, et al., Immobilization of human thrombomodulin onto PTFE. J Mater Sci Mater Med. 1997;8(12):789-91.
193. Sperling C, Schweiss RB, Streller U and Werner C, In vitro hemocompatibility of self-assembled monolayers displaying various functional groups. Biomaterials, 2005;26(33):6547-57.
194. Sterpetti AV, Cucina A, Randone B, Palumbo R, Stipa F, Proietti P, et al., Growth factor production by arterial and vein grafts: Relevance to coronary artery bypass grafting. Surgery. 1996;120(3):460-7.
195. Sterpetti AV, Cucina A, Lepidi S, Randone B, Corvino V, D'Angelo LS, et al., Formation of myointimal hyperplasia and cytokine production in experimental vein grafts. Surgery. 1998;123(4):461-9.
196. Sun LB, Utoh J, Moriyama S, Tagami H, Okamoto K and Kitamura N, Pretreatment of a Dacron graft with tissue factor pathway inhibitor decreases thrombogenicity and neointimal thickness: A preliminary animal study. ASAIO J. 2001;47(4):325-8.
197. Sun LB, Utoh J, Moriyama S, Tagami H, Okamoto K and Kitamura N, Topically applied tissue factor pathway inhibitor reduced intimal thickness of small arterial autografts in rabbits. J Vasc Surg.2001;34(1):151-5.
198. Swartz DD, Russell JA and Andreadis ST, Engineering of fibrin-based functional and implantable small-diameter blood vessels. J Vasc Surg.2006;43(4):867.
199. Tai NR, Salacinski HJ, Edwards A, Hamilton G and Seifalian AM. Compliance properties of conduits used in vascular reconstruction. Br J Surg. 2000;87:1516-24.
200. Taite LJ, Yang P, Jun H-W and West JL, Nitric oxidereleasing polyurethane-PEG copolymer containing the YIGSR peptide promotes endothelialization with decreased platelet adhesion. J Biomed Mater Res B Appl Biomater. 2008;84(1):108-16.
201. Takahashi K, Adsorption of basic fibroblast growth factor onto Dacron vascular prosthesis and its biological efficacy. Artif Organs.1997;21(9):1041-6.
202. Tao S-f, Chen L, Zheng Y-x, Xu Y, Chen J and Yu H, Proliferation of endothelial cell on polytetrafluoroethylene vascular graft materials carried VEGF gene plasmid. Journal of Zhejiang University. Science. B, 2006;7(6):421-8.
203. Tieche C, Alkema PK and Liu SQ, Vascular elastic laminae: Anti-inflammatory properties and potential applications to arterial reconstruction. Front Biosci. 2004;9:2205-17.
204. Tiwari A, Salacinski H, Seifalian AM and Hamilton G, New prostheses for use in bypass grafts with special emphasis on polyurethanes. Cardiovasc Surgery. 2002;10(3):191-7.
205. Tseng PY, Rele SS, Sun XL and Chaikof EL, Membranemimetic films containing thrombomodulin and heparin inhibit tissue factor-induced thrombin generation in a flow. Biomaterials, 2006;27(12):2637-50.
206. van der Lei B, Bartels HL, Robinson PH and Bakker WW, Reduced thrombogenicity of vascular prostheses by coating with ADP-ase. Int Angiol. 1992;11(4):268-71.
207. van Hinsbergh VW, Kooistra T, Scheffer MA, Hajo van Bockel J and van Muijen GN, Characterization and fibrinolytic properties of human omental tissue mesothelial cells. Comparison with endothelial cells. Blood, 1990;75(7):1490-7.
208. Vara DS, Salacinski HJ, Kannan RY, Bordenave L, Hamilton G and Seifalian AM, Cardiovascular tissue engineering: State of the art. Pathologie-biologie, 2005;53(10):599-612.
209. Vaughn MW, Kuo L and Liao JC, Estimation of nitric oxide production and reaction rates in tissue by use of a mathematical model. Am J Phys. 1998;274(6 Pt 2):2163-76.
210. Verhagen HJ, Heijnen-Snyder GJ, Pronk A, Vroom TM, van Vroonhoven TJ, Eikelboom BC, et al., Thrombomodulin activity on mesothelial cells: perspectives for mesothelial cells as an alternative for endothelial cells for cell seeding on vascular grafts. Br J Haematol. 1996;95(3):542-9.
211. Verhagen HJM, Blankensteijn JD, de Groot PG, Heijnen- Snyder GJ, Pronk A, Vroom TM, et al., In Vivo experiments with mesothelial cell seeded ePTFE vascular grafts. Eur J Vasc Endovasc Surg. 1998;15(6):489-96.
212. Vermette P, Gauvreau V, Pézolet M and Laroche G, Albumin and fibrinogen adsorption onto phosphatidylcholine monolayers investigated by Fourier transform infrared spectroscopy. Colloids Surf B Biointerfaces. 2003;29(4):285-95.
213. Vinard E, Lesèche G, Andreassian B and Costagliola D, In Vitro Endothelialization of PTFE Vascular Grafts: A Comparison of Various Substrates, Cell Densities, and Incubation Times. Ann Vasc Surg.1999;13(2):141-50.
214. Viscardi PJ, Page EA, Clark HG, Serafin D and Klitzman B, Iloprost in alginate decreases the thrombogenicity of expanded polytetrafluoroethylene. J Reconstr Microsurg. 1997;13(4):303-6.
215. Vohra RK, Thompson GJ, Sharma H, Carr HM and Walker MG, Fibronectin coating of expanded polytetrafluoroethylene (ePTFE) grafts and its role in endothelial seeding. Artif Organs.1990;14(1):41-5.
216. Voorhees AB, Jaretzki A and Blakemore AH, The use of tubes constructed from vinyon N cloth in bridging arterial defects. Annals of Surgery. 1952;135(3):332-6.
217. Vural KM and Bayazit M, Nitric Oxide: Implications for Vascular and Endovascular Surgery. Eur J Vasc Endovasc Surg. 2001;22(4):285-93.
218. Wake MC, Gupta PK and Mikos AG, Fabrication of pliable biodegradable polymer foams to engineer soft tissues. Cell Transplantation, 1996;5(4):465-73.
219. Walden R, L'Italien GJ, Megerman J and Abbott WM, Matched elastic properties and successful arterial grafting. Arch Surg. 1980;115(10):1166-9.
220. Walpoth BH and Bowlin GL, The daunting quest for a small diameter vascular graft. Exp Rev Med Dev. 2005;2(6):647-51.
221. Walpoth BH, Zammaretti P, Cikirikcioglu M, Khabiri E, Djebaili MK, Pache J-C, et al., Enhanced intimal thickening of expanded polytetrafluoroethylene grafts coated with fibrin or fibrin-releasing vascular endothelial growth factor in the pig carotid artery interposition model. J Thorac Cardiovasc Surg.2007;133(5):1163-70.
222. Walpoth BH, Zammaretti P, Cikirikcioglu M, Khabiri E, Djebaili MK, Pache JC, et al., Enhanced intimal thickening of expanded polytetrafluoroethylene grafts coated with fibrin or fibrin-releasing vascular. J Thorac Cardiovasc Surg.2007;133(5):1163-70.
223. Wasiewski W, Fasco MJ, Martin BM, Detwiler TC and Fenton JW, Thrombin adsorption to surfaces and prevention with polyethylene glycol 6, 000. Thromb Res.1976;8(6):881-6.
224. Watanabe M, Shin'oka T, Tohyama S, Hibino N, Konuma T, Matsumura G, et al., Tissue-engineered vascular autograft: Inferior vena cava replacement in a dog model. Tissue Eng.2001;7(4):429-39.
225. Weinberg CB and Bell E, A blood vessel model constructed from collagen and cultured vascular cells. Science. 1986;231(4736):397-400.
226. Weiss HJ, Turitto VT and Baumgartner HR, Platelet adhesion and thrombus formation on subendothelium in platelets deficient in glycoproteins IIb-IIIa, Ib, and storage granules. Blood. 1986;67:322-30.
227. Westedt U, Kalinowski M, Wittmar M, Merdan T, Unger F, Fuchs J, et al., Poly(vinyl alcohol)-graft-poly(lactide-coglycolide) nanoparticles for local delivery of paclitaxel for restenosis treatment. J Control Rel. 2007;119(1):41-51.
228. Whelan DM, van der Giessen WJ, Krabbendam SC, van Vliet EA, Verdouw PD, Serruys PW, et al., Biocompatibility of phosphorylcholine coated stents in normal porcine coronary arteries. Heart. 2000;83(3):338-45.
229. Williams SK, Jarrell BE and Kleinert LB, Endothelial cell transplantation onto polymeric arteriovenous grafts evaluated using a canine model. J Investig Surg.1994;7(6):503-17.
230. Wissink MJB, Beernink R, Scharenborg NM, Poot AA, Engbers GHM, Beugeling T, et al., Endothelial cell seeding of (heparinized) collagen matrices: effects of bFGF preloading on proliferation (after low density seeding) and procoagulant factors. J Control Rel. 2000;67(2-3):141-55.
231. Wong G, Li J-m, Hendricks G, Eslami MH, Rohrer MJ and Cutler BS, Inhibition of experimental neointimal hyperplasia by recombinant human thrombomodulin coated ePTFE stent grafts. J Vasc Surg. 2008;47(3):608-15.
232. Woodhouse KA, Klement P, Chen V, Gorbet MB, Keeley FW, Stahl R, et al., Investigation of recombinant human elastin polypeptides as non-thrombogenic coatings. Biomaterials, 2004;25(19):4543-53.
233. Wu B, Gerlitz B, Grinnell BW and Meyerhoff ME, Polymeric coatings that mimic the endothelium: Combining nitric oxide release with surface-bound active thrombomodulin. Biomaterials, 2007;28(28):4047-55.
234. Wyers MC, Phaneuf MD, Rzucidlo EM, Contreras MA, LoGerfo FW and Quist WC, In Vivo Assessment of a Novel Dacron Surface with Covalently Bound Recombinant Hirudin. Cardiovasc Pathol. 1999;8(3):153-9.
235. Yang Y, Li Q, Ertl HC and Wilson JM, Cellular and humoral immune responses to viral antigens create barriers to lungdirected gene therapy with recombinant adenoviruses. J Virol. 1995;69(4):2004-15.
236. Yang J, Motlagh D, Allen JB, Webb AR, Kibbe MR, Aalami O, et al., Modulating Expanded Polytetrafluoroethylene Vascular Graft Host Response via Citric Acid-Based Biodegradable Elastomers. Adv Mater. 2006;18(12):1493-8.
237. Yoon C-H, Hur J, Park K-W, Kim J-H, Lee C-S, Oh I-Y, et al., Synergistic neovascularization by mixed transplantation of early endothelial progenitor cells and late outgrowth endothelial cells: The role of angiogenic cytokines and matrix metalloproteinases. Circulation, 2005;112(11):1618-27.
238. Yow KH, Ingram J, Korossis SA, Ingham E and Homer- Vanniasinkam S, Tissue engineering of vascular conduits. Br J Surg.2006;93(6):652-61.
239. Zavan B, Vindigni V, Lepidi S, Iacopetti I, Avruscio G, Abatangelo G, et al., Neoarteries grown in vivo using a tissue-engineered hyaluronan-based scaffold. FASEB J. 2008;22(8):2853-61.
240. Zhang Q, Wang C, Babukutty Y, Ohyama T, Kogoma M and Kodama M. Biocompatibility evaluation of ePTFE membrane modified with PEG in atmospheric pressure glow discharge. J Biomed Mat Res. 2002;60:502-9.
241. Zhu C, Ying D, Mi J, Li L, Zeng W, Hou C, et al., Development of anti-atherosclerotic tissue-engineered blood vessel by A20-regulated endothelial progenitor cells seeding decellularized vascular matrix. Biomaterials, 2008;29(17):2628-36.
242. Zhu J, Grace M, Casale J, Chang AT, Musco ML, Bordens R, et al., Characterization of replication-competent adenovirus isolates from large-scale production of a recombinant adenoviral vector. Hum Gene Ther. 1999;10(1):113-21.
243. Zhu W, Masaki T, Cheung AK and Kern SE, Cellular pharmacokinetics and pharmacodynamics of dipyridamole in vascular smooth muscle cells. Biochem Pharmacol. 2006;72(8):956-64.
244. Zilla P, Bezuidenhout D and Human P, Prosthetic vascular grafts: Wrong models, wrong questions and no healing. Biomaterials, 2007;28(34):5009-27.
245. Zisch AH, Zeisberger SM, Ehrbar M, Djonov V, Weber CC, Ziemiecki A, et al., Engineered fibrin matrices for functional display of cell membrane-bound growth factorlike activities: Study of angiogenic signaling by ephrin-B2. Biomaterials, 2004;25(16):3245-57.